Notably, TREM2 KO models exhibit robust neuroprotection in tauopathies, achieving reduced microglial overactivation, alleviation of neuroinflammation, and inhibition of neurodegeneration compared to wild type [158, 339]. This evidence concerns the gene TREM2 and tauopathy.